Compounded oral tirzepatide
Compounded Oral Tirzepatide: FDA Context and Questions to Ask
Compounded drugs are not FDA-approved, which means FDA does not review them for safety, effectiveness, or quality before marketing. They should not be presented as the same as an FDA-approved drug.
Understand what the word “compounded” means
Ask the clinician and pharmacy to explain the product, its route, why it is being considered, the written directions, and who can answer questions. FDA provides current consumer information about unapproved GLP-1 drugs.
Questions to bring to a clinician or provider
- Is the product compounded or FDA-approved?
- What is the exact route and formulation?
- Which pharmacy will dispense it?
- Where can you find written directions and safety information?
Review program details carefully
Before exploring an online option, review the provider’s current product details, clinical process, pharmacy information, full costs, and follow-up support. This is educational information, not medical advice.